This is a registry record, not a result. A trial being listed, recruiting or completed says nothing by itself about whether the compound works or is safe.
| Registry number | NCT00481104 |
|---|---|
| Status | Completed |
| Phase | Phase 2 |
| Sponsor | NeuroSearch A/S |
| Enrollment | 140 participants |
| Design | Interventional, Na, Single Group, Masking: None |
| Conditions | Obesity |
| Interventions | Tesofensine |
| Start | May 2007 |
| Primary completion | Sep 2008 |
| Study completion | Nov 2008 |
| Results posted | Not yet |
| Registry last updated | Jul 4, 2011 |
Compounds on this site that cite this trial
What the registry says the trial is about
Purpose of the study is to evaluate the long term safety of tesofensine in obese patients
Primary outcomes
These are what the trial was designed to measure first. They are registered in advance, which is what makes a later result checkable.
| Outcome measure | Time frame |
|---|---|
| Safety measures: Treatment emergent adverse events, vital signs (BP and HR), ophthalmoscopy, ECG, laboratory assessments and physical examination |
1 secondary outcome also registered. See the registry record for the full list.
Source: ClinicalTrials.gov (U.S. National Library of Medicine). Last checked against the registry on Oct 3, 2026. See the trial changes feed for what has changed recently.
